# Paul La Porte, M.D. – FDA Inspection, Mar 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/paul-la-porte-md/42e75700-74eb-4482-b9db-77146f50dce7
Source feed: FDA_Inspections

> FDA inspection 1234361 of Paul La Porte, M.D., March 28, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234361
- Company Name: Paul La Porte, M.D.
- Inspection Date: 2024-03-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1314738 - 2026-04-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jasmine-y-wang/e23c7335-477c-4671-8dcc-72e9149d424e)
- [Issuing Officer](https://www.keypedia.com/people/raman-k-kaushal/fbf1abb7-2303-433e-a56d-2622e29f62c8)

Company: https://www.keypedia.com/companies/paul-la-porte-md/af6b988c-fece-41ab-83c2-110564acbe92

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c